Total Trades
Politicians Trading
Last Traded
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
Total Trades
Politicians Trading
Last Traded
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
$171.99updated Apr 14, 2026
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Total Trades
6
Politicians Trading
3
Last Traded
Dec 29, 2025
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Markwayne MullinR | Jan 16, 2026 | Dec 29, 2025 | Buy | $15,001 – $50,000 | -24.27% |
| John BoozmanR | Nov 15, 2025 | Oct 2, 2025 | Sell | $1,001 – $15,000 | -15.83% |
| Robert BresnahanR | May 31, 2025 | May 15, 2025 | Sell | $1,001 – $15,000 | +22.47% |
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Buy | $15,001 – $50,000 | +19.03% |
| Robert BresnahanR | Mar 27, 2025 | Feb 25, 2025 | Sell | $1,001 – $15,000 | -9.94% |
| Markwayne MullinR | Feb 27, 2025 | Feb 13, 2025 | Buy | $15,001 – $50,000 | -12.27% |